DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAAR) Operating cash flow
DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAAR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$539,187FY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$539,187 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DMAAR financial trends
DMAAR RevenueDMAAR Net incomeDMAAR Net marginDMAAR Gross profitDMAAR Gross marginDMAAR Operating incomeDMAAR Operating marginDMAAR Free cash flowDMAAR Capital expendituresDMAAR Return on equityDMAAR Stock buybacksDMAAR Dividends paidDMAAR Total assetsDMAAR Total liabilitiesDMAAR Shareholders’ equityDMAAR overview →